Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gabardi

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Pharmacotherapy|September 30, 2010
Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiologySteven Gabardi, Steven A Baroletti
Progress in Transplantation (Aliso Viejo, Calif.)|March 2, 2013
A guide to understanding and implementing risk evaluation and mitigation strategies in organ transplantationSteven Gabardi, Eric M Tichy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2012
Current trends in immunosuppressive therapies for renal transplant recipientsRuth-Ann Lee, Steven Gabardi
The Annals of Pharmacotherapy|December 2, 2010
Comment: management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategiesSteven Gabardi, Steven A Baroletti
Transplantation|April 5, 2017
Causes and Consequences of the Worldwide Belatacept ShortageSteven Gabardi, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|February 28, 2013
Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugsTeun van Gelder, Steven Gabardi
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
A review of dietary supplement-induced renal dysfunctionSteven Gabardi, Kristin Munz, Catherine Ulbricht
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2003
Bitter melon (Momordica charantia): a review of efficacy and safetyEthan Basch, Steven Gabardi, Catherine Ulbricht
Progress in Transplantation (Aliso Viejo, Calif.)|March 7, 2014
Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparationsSara Rostas, Miae Kim, Steven Gabardi
Journal of Pharmacy Practice|June 6, 2015
Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?Karen Phillips, Prabashni Reddy, Steven Gabardi
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Pharmacotherapy|September 30, 2010
Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiologySteven Gabardi, Steven A Baroletti
Progress in Transplantation (Aliso Viejo, Calif.)|March 2, 2013
A guide to understanding and implementing risk evaluation and mitigation strategies in organ transplantationSteven Gabardi, Eric M Tichy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2012
Current trends in immunosuppressive therapies for renal transplant recipientsRuth-Ann Lee, Steven Gabardi
The Annals of Pharmacotherapy|December 2, 2010
Comment: management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategiesSteven Gabardi, Steven A Baroletti
Transplantation|April 5, 2017
Causes and Consequences of the Worldwide Belatacept ShortageSteven Gabardi, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|February 28, 2013
Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugsTeun van Gelder, Steven Gabardi
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
A review of dietary supplement-induced renal dysfunctionSteven Gabardi, Kristin Munz, Catherine Ulbricht
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2003
Bitter melon (Momordica charantia): a review of efficacy and safetyEthan Basch, Steven Gabardi, Catherine Ulbricht
Progress in Transplantation (Aliso Viejo, Calif.)|March 7, 2014
Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparationsSara Rostas, Miae Kim, Steven Gabardi
Journal of Pharmacy Practice|June 6, 2015
Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?Karen Phillips, Prabashni Reddy, Steven Gabardi
Pageof 7